The controversial anti-fat drug Xenical has been given a new lease of life, with the announcement of a special financial arrangement between pharmacists and Swiss drug giant Roche, writes Ray Moynihan.
The controversial anti-fat drug Xenical has been given a new lease of life, with the announcement of a special financial arrangement between pharmacists and Swiss drug giant Roche, writes Ray Moynihan.